Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2011; 105(05): 925-927
DOI: 10.1160/TH10-11-0724
DOI: 10.1160/TH10-11-0724
Letters to the Editor
As many as 12 cases with haemorrhagic acquired factor XIII deficiency due to its inhibitors were recently found in Japan
Authors
Further Information
Publication History
Received:
13 November 2010
Accepted after minor revision:
14 January 2011
Publication Date:
28 November 2017 (online)
1 A list of groupup members is given in the Appendix.
2 happening frequently in clinical scenes, even in the official journal of the International Society of Thrombosis and Hemostasis as well as in PubMed.
3 detailed characterisation of their antibodies will be reported elsewhere in the future.
-
References
- 1 Lorand L. Acquired inhibitors of fibrin stabilization: A class of hemorrhagic disorders of diverse origins. In: Anticoagulants, Physiologic, Pathologic and Pharmacologic. Boca Raton, FL: CRC Press; 1994. pp. 169-191.
- 2 Egbring R, Kröniger A, Seitz R. Erworbene Inhibitoren gegen Faktor XIII. Hämostaseologie 1996; 16: 174-179.
- 3 Teruya J, Kinoshita T, Yoshimura Y. et al. An inhibitor to factor XIII interacting with its activated catalytic subunit. Rinsho Ketsueki 1986; 27: 1680-1687.
- 4 Nakamura S, Kato A, Sakata Y. et al. Bleeding tendency caused by IgG inhibitor to factor XIII, treated successfully by cyclophosphamide. Br J Haematol 1988; 68: 313-319.
- 5 Lorand L, Velasco PT, Hill JM. et al. Intracranial hemorrhage in systemic lupus erythematosus associated with an autoantibody against actor XIII. Thromb Haemost 2002; 88: 919-923.
- 6 Nijenhuis AV, van Bergeijk L, Huijgens PC. et al. Acquired factor XIII deficiency due to an inhibitor: a case report and review of the literature. Haematologica 2004; 89: e46-e48.
- 7 Miesbach W. Rituximab in the treatment of factor XIII inhibitor possibly caused by Ciprofloxacin. Thromb Haemost 2005; 93: 1001-1003.
- 8 Lim W, Moffat K, Hayward CP. Prophylactic and peri-operative replacement therapy for acquired factor XIII deficiency. J Thromb Haemost 2004; 2: 1017-1019.
- 9 Ajzner E, Schlammadinger A, Kerényi A. et al. Severe bleeding complications caused by an autoanti-body against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency. Blood 2009; 113: 723-725.
- 10 Green D, Lechner K. A survey of 215 non-hemophilic patients with inhibitors to Factor VIII. Thromb Haemost 1981; 45: 200-203.
- 11 Collins PW, Hirsch S, Baglin TP. et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors’ Organisation. Blood 2007; 109: 1870-1877.
- 12 Morrison AE, Ludlam CA, Kessler C. Use of porcine factor VIII in the treatment of patients with acquired hemophilia. Blood 1993; 81: 1513-1520.
- 13 Ishida F, Okubo K, Ito T. et al. Spontaneous regression of the inhibitor against the coagulation factor XIII A subunit in acquired factor XIII deficiency. Thromb Haemost 2010; 104: 1284-1285.